The global Inhalation Anesthesia market was valued at US$ 1355 million in 2025 and is anticipated to reach US$ 1798 million by 2032, at a CAGR of 4.1% from 2026 to 2032.

Inhalation Anesthesia Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Inhalation Anesthesia competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Inhalation anesthesia are volatile liquids or gases administered through the lungs to produce and maintain general anesthesia, allowing patients to become unconscious and insensitive to pain during surgery or certain procedures. They are delivered via an anesthesia machine and vaporizer (for volatile agents) or as a medical gas, mixed with oxygen and sometimes nitrous oxide, and the dose is adjusted by controlling the inspired concentration; because they are absorbed into the bloodstream from the alveoli and then act on the central nervous system, their onset and recovery depend on factors like solubility, ventilation, cardiac output, and how quickly the agent is eliminated through exhalation. Common modern volatile Inhalation anesthesia include sevoflurane, desflurane, and isoflurane, while nitrous oxide is used as an adjunct; these agents are valued for reliable titratability, rapid control of anesthetic depth, and broad applicability across many surgical settings, with selection often guided by patient factors, equipment availability, cost, and safety/environmental considerations. The product has an average price of $200-350 per kilogram and a production volume of approximately 5,000 tons per year.

Upstream for Inhalation anesthesia centers on specialty fluorine and fine-chemical supply chains: petrochemical feedstocks are converted into high-purity fluorinated intermediates and then into volatile agents such as sevoflurane, desflurane, and isoflurane (fluorinated ethers), followed by pharmaceutical-grade purification, stability/impurity control, and GMP fill-finish into vaporizer bottles/cylinders with compliant packaging and QA release. The midstream channel is dominated by regulated pharma distribution (manufacturers → national wholesalers/GPOs → hospital pharmacies/OR supply), alongside the anesthesia equipment ecosystem (vaporizers, anesthesia workstations, breathing circuits, and increasingly waste-gas management). Downstream, consumption is primarily in hospitals and ambulatory surgery centers (general anesthesia maintenance and adjunct use), with additional demand from dental sedation services and veterinary anesthesia, and utilization is shaped by clinical protocols (fresh-gas-flow practices, agent selection) and facility infrastructure (central gas systems, scavenging).

The segment is mature and closely tied to surgical volumes, but competitive dynamics are increasingly driven by environmental policy and decarbonization in healthcare, because most inhaled agents are vented largely unchanged and can have high climate impact; professional guidance and research consistently flag desflurane as the most climate-intensive among common volatile agents. As a result, major systems have moved to restrict or decommission desflurane (e.g., NHS England limiting routine use from April 2024) and the EU has rules that prohibit routine desflurane use from 1 January 2026 except when medically justified, pushing formularies toward sevoflurane/isoflurane, lower-flow techniques, and in some cases greater use of TIVA where clinically appropriate. At the same time, suppliers and hospitals are investing in “greener anesthesia” levers—better monitoring and low-flow optimization, selective nitrous oxide infrastructure reduction, and emerging capture/destruction solutions—so differentiation is shifting from “just supply” toward emissions-aware clinical support, compliance documentation, and system-level implementation.

This report delivers a comprehensive overview of the global Inhalation Anesthesia market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inhalation Anesthesia. The Inhalation Anesthesia market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Inhalation Anesthesia market comprehensively. Regional market sizes by Type, by Application, by MAC, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Inhalation Anesthesia manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Inhalation Anesthesia Market Report

Report Metric	Details
Report Name	Inhalation Anesthesia Market
Accounted market size in 2025	US$ 1355 million
Forecasted market size in 2032	US$ 1798 million
CAGR	4.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Heptafluoroane Desflurane Isoflurane Others
Segment by MAC	Below 3% Above 3%
Segment by Chemical Structure	Volatile Gases Liquids
by Application	Human Use Animal Use
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by MAC, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Inhalation Anesthesia manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Inhalation Anesthesia sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Inhalation Anesthesia Market growing?

Ans: The Inhalation Anesthesia Market witnessing a CAGR of 4.1% during the forecast period 2026-2032.

What is the Inhalation Anesthesia Market size in 2032?

Ans: The Inhalation Anesthesia Market size in 2032 will be US$ 1798 million.

Who are the main players in the Inhalation Anesthesia Market report?

Ans: The main players in the Inhalation Anesthesia Market are Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer

What are the Application segmentation covered in the Inhalation Anesthesia Market report?

Ans: The Applications covered in the Inhalation Anesthesia Market report are Human Use, Animal Use

What are the Type segmentation covered in the Inhalation Anesthesia Market report?

Ans: The Types covered in the Inhalation Anesthesia Market report are Heptafluoroane, Desflurane, Isoflurane, Others

1 Inhalation Anesthesia Market Overview

1.1 Product Definition

1.2 Inhalation Anesthesia by Type

1.2.1 Global Inhalation Anesthesia Market Value by Type: 2025 vs 2032

1.2.2 Heptafluoroane

1.2.3 Desflurane

1.2.4 Isoflurane

1.2.5 Others

1.3 Inhalation Anesthesia by MAC

1.3.1 Global Inhalation Anesthesia Market Value by MAC: 2025 vs 2032

1.3.2 Below 3%

1.3.3 Above 3%

1.4 Inhalation Anesthesia by Chemical Structure

1.4.1 Global Inhalation Anesthesia Market Value by Chemical Structure: 2025 vs 2032

1.4.2 Volatile Gases

1.4.3 Liquids

1.5 Inhalation Anesthesia by Application

1.5.1 Global Inhalation Anesthesia Market Value by Application: 2025 vs 2032

1.5.2 Human Use

1.5.3 Animal Use

1.6 Global Inhalation Anesthesia Market Size Estimates and Forecasts

1.6.1 Global Inhalation Anesthesia Revenue 2021–2032

1.6.2 Global Inhalation Anesthesia Sales 2021–2032

1.6.3 Global Inhalation Anesthesia Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Inhalation Anesthesia Market Competition by Manufacturers

2.1 Global Inhalation Anesthesia Sales Market Share by Manufacturers (2021–2026)

2.2 Global Inhalation Anesthesia Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Inhalation Anesthesia Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Inhalation Anesthesia, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Inhalation Anesthesia, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Inhalation Anesthesia, Product Types and Applications

2.7 Global Key Manufacturers of Inhalation Anesthesia, Date of Entry into the Industry

2.8 Global Inhalation Anesthesia Market Competitive Situation and Trends

2.8.1 Global Inhalation Anesthesia Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Inhalation Anesthesia Players Market Share by Revenue

2.8.3 Global Inhalation Anesthesia Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Inhalation Anesthesia Market Scenario by Region

3.1 Global Inhalation Anesthesia Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Inhalation Anesthesia Sales by Region: 2021–2032

3.2.1 Global Inhalation Anesthesia Sales by Region: 2021–2026

3.2.2 Global Inhalation Anesthesia Sales by Region: 2027–2032

3.3 Global Inhalation Anesthesia Revenue by Region: 2021–2032

3.3.1 Global Inhalation Anesthesia Revenue by Region: 2021–2026

3.3.2 Global Inhalation Anesthesia Revenue by Region: 2027–2032

3.4 North America Inhalation Anesthesia Market Facts & Figures by Country

3.4.1 North America Inhalation Anesthesia Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Inhalation Anesthesia Sales by Country (2021–2032)

3.4.3 North America Inhalation Anesthesia Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Inhalation Anesthesia Market Facts & Figures by Country

3.5.1 Europe Inhalation Anesthesia Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Inhalation Anesthesia Sales by Country (2021–2032)

3.5.3 Europe Inhalation Anesthesia Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Inhalation Anesthesia Market Facts & Figures by Region

3.6.1 Asia Pacific Inhalation Anesthesia Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Inhalation Anesthesia Sales by Region (2021–2032)

3.6.3 Asia Pacific Inhalation Anesthesia Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Inhalation Anesthesia Market Facts & Figures by Country

3.7.1 Latin America Inhalation Anesthesia Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Inhalation Anesthesia Sales by Country (2021–2032)

3.7.3 Latin America Inhalation Anesthesia Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Inhalation Anesthesia Market Facts & Figures by Country

3.8.1 Middle East and Africa Inhalation Anesthesia Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Inhalation Anesthesia Sales by Country (2021–2032)

3.8.3 Middle East and Africa Inhalation Anesthesia Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Inhalation Anesthesia Sales by Type (2021–2032)

4.1.1 Global Inhalation Anesthesia Sales by Type (2021–2026)

4.1.2 Global Inhalation Anesthesia Sales by Type (2027–2032)

4.1.3 Global Inhalation Anesthesia Sales Market Share by Type (2021–2032)

4.2 Global Inhalation Anesthesia Revenue by Type (2021–2032)

4.2.1 Global Inhalation Anesthesia Revenue by Type (2021–2026)

4.2.2 Global Inhalation Anesthesia Revenue by Type (2027–2032)

4.2.3 Global Inhalation Anesthesia Revenue Market Share by Type (2021–2032)

4.3 Global Inhalation Anesthesia Price by Type (2021–2032)

5 Segment by Application

5.1 Global Inhalation Anesthesia Sales by Application (2021–2032)

5.1.1 Global Inhalation Anesthesia Sales by Application (2021–2026)

5.1.2 Global Inhalation Anesthesia Sales by Application (2027–2032)

5.1.3 Global Inhalation Anesthesia Sales Market Share by Application (2021–2032)

5.2 Global Inhalation Anesthesia Revenue by Application (2021–2032)

5.2.1 Global Inhalation Anesthesia Revenue by Application (2021–2026)

5.2.2 Global Inhalation Anesthesia Revenue by Application (2027–2032)

5.2.3 Global Inhalation Anesthesia Revenue Market Share by Application (2021–2032)

5.3 Global Inhalation Anesthesia Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Company Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Baxter Inhalation Anesthesia Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 AbbVie

6.2.1 AbbVie Company Information

6.2.2 AbbVie Description and Business Overview

6.2.3 AbbVie Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 AbbVie Inhalation Anesthesia Product Portfolio

6.2.5 AbbVie Recent Developments/Updates

6.3 Piramal Critical Care

6.3.1 Piramal Critical Care Company Information

6.3.2 Piramal Critical Care Description and Business Overview

6.3.3 Piramal Critical Care Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Piramal Critical Care Inhalation Anesthesia Product Portfolio

6.3.5 Piramal Critical Care Recent Developments/Updates

6.4 Fresenius Kabi

6.4.1 Fresenius Kabi Company Information

6.4.2 Fresenius Kabi Description and Business Overview

6.4.3 Fresenius Kabi Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Fresenius Kabi Inhalation Anesthesia Product Portfolio

6.4.5 Fresenius Kabi Recent Developments/Updates

6.5 Halocarbon

6.5.1 Halocarbon Company Information

6.5.2 Halocarbon Description and Business Overview

6.5.3 Halocarbon Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Halocarbon Inhalation Anesthesia Product Portfolio

6.5.5 Halocarbon Recent Developments/Updates

6.6 Aspen

6.6.1 Aspen Company Information

6.6.2 Aspen Description and Business Overview

6.6.3 Aspen Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Aspen Inhalation Anesthesia Product Portfolio

6.6.5 Aspen Recent Developments/Updates

6.7 Pfizer

6.7.1 Pfizer Company Information

6.7.2 Pfizer Description and Business Overview

6.7.3 Pfizer Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Pfizer Inhalation Anesthesia Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Maruishi Pharmaceutical

6.8.1 Maruishi Pharmaceutical Company Information

6.8.2 Maruishi Pharmaceutical Description and Business Overview

6.8.3 Maruishi Pharmaceutical Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Maruishi Pharmaceutical Inhalation Anesthesia Product Portfolio

6.8.5 Maruishi Pharmaceutical Recent Developments/Updates

6.9 Jiangsu Hengrui Medicine

6.9.1 Jiangsu Hengrui Medicine Company Information

6.9.2 Jiangsu Hengrui Medicine Description and Business Overview

6.9.3 Jiangsu Hengrui Medicine Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Jiangsu Hengrui Medicine Inhalation Anesthesia Product Portfolio

6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates

6.10 Lunan Pharmaceutical

6.10.1 Lunan Pharmaceutical Company Information

6.10.2 Lunan Pharmaceutical Description and Business Overview

6.10.3 Lunan Pharmaceutical Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Lunan Pharmaceutical Inhalation Anesthesia Product Portfolio

6.10.5 Lunan Pharmaceutical Recent Developments/Updates

6.11 Hikma Pharmaceuticals

6.11.1 Hikma Pharmaceuticals Company Information

6.11.2 Hikma Pharmaceuticals Description and Business Overview

6.11.3 Hikma Pharmaceuticals Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Hikma Pharmaceuticals Inhalation Anesthesia Product Portfolio

6.11.5 Hikma Pharmaceuticals Recent Developments/Updates

6.12 HeBei YiPin Pharmaceutical

6.12.1 HeBei YiPin Pharmaceutical Company Information

6.12.2 HeBei YiPin Pharmaceutical Description and Business Overview

6.12.3 HeBei YiPin Pharmaceutical Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 HeBei YiPin Pharmaceutical Inhalation Anesthesia Product Portfolio

6.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates

6.13 Dechra Pharmaceuticals

6.13.1 Dechra Pharmaceuticals Company Information

6.13.2 Dechra Pharmaceuticals Description and Business Overview

6.13.3 Dechra Pharmaceuticals Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Dechra Pharmaceuticals Inhalation Anesthesia Product Portfolio

6.13.5 Dechra Pharmaceuticals Recent Developments/Updates

6.14 Life Sciences

6.14.1 Life Sciences Company Information

6.14.2 Life Sciences Description and Business Overview

6.14.3 Life Sciences Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Life Sciences Inhalation Anesthesia Product Portfolio

6.14.5 Life Sciences Recent Developments/Updates

6.15 Zhejiang AngLiKang Pharmaceutical

6.15.1 Zhejiang AngLiKang Pharmaceutical Company Information

6.15.2 Zhejiang AngLiKang Pharmaceutical Description and Business Overview

6.15.3 Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Product Portfolio

6.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates

6.16 Linde Healthcare

6.16.1 Linde Healthcare Company Information

6.16.2 Linde Healthcare Description and Business Overview

6.16.3 Linde Healthcare Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Linde Healthcare Inhalation Anesthesia Product Portfolio

6.16.5 Linde Healthcare Recent Developments/Updates

6.17 Air Liquide

6.17.1 Air Liquide Company Information

6.17.2 Air Liquide Description and Business Overview

6.17.3 Air Liquide Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Air Liquide Inhalation Anesthesia Product Portfolio

6.17.5 Air Liquide Recent Developments/Updates

6.18 Messer

6.18.1 Messer Company Information

6.18.2 Messer Description and Business Overview

6.18.3 Messer Inhalation Anesthesia Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Messer Inhalation Anesthesia Product Portfolio

6.18.5 Messer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Inhalation Anesthesia Industry Chain Analysis

7.2 Inhalation Anesthesia Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Inhalation Anesthesia Production Mode & Process Analysis

7.4 Inhalation Anesthesia Sales and Marketing

7.4.1 Inhalation Anesthesia Sales Channels

7.4.2 Inhalation Anesthesia Distributors

7.5 Inhalation Anesthesia Customer Analysis

8 Inhalation Anesthesia Market Dynamics

8.1 Inhalation Anesthesia Industry Trends

8.2 Inhalation Anesthesia Market Drivers

8.3 Inhalation Anesthesia Market Challenges

8.4 Inhalation Anesthesia Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AbbVie

Baxter

Piramal Critical Care

Maruishi Pharmaceutical

Jiangsu Hengrui Medicine

Lunan Pharmaceutical

Hikma Pharmaceuticals

Hebei Yipin Pharmaceutical

Dechra Pharmaceuticals

Life Sciences

Zhejiang Anglikang Pharmaceutical

Linde Healthcare

Air Liquide

Messer

List of Tables

Table 1. Global Inhalation Anesthesia Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Inhalation Anesthesia Market Value by MAC (US$ Million), 2025 vs 2032

Table 3. Global Inhalation Anesthesia Market Value by Chemical Structure (US$ Million), 2025 vs 2032

Table 4. Global Inhalation Anesthesia Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Inhalation Anesthesia Market Competitive Situation by Manufacturers in 2025

Table 6. Global Inhalation Anesthesia Sales (Tons) of Key Manufacturers (2021–2026)

Table 7. Global Inhalation Anesthesia Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Inhalation Anesthesia Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Inhalation Anesthesia Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Inhalation Anesthesia Average Price (US$/kg) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Inhalation Anesthesia, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Inhalation Anesthesia, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Inhalation Anesthesia, Product Types and Applications

Table 14. Global Key Manufacturers of Inhalation Anesthesia, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Inhalation Anesthesia Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhalation Anesthesia Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Inhalation Anesthesia Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Inhalation Anesthesia Sales by Region (Tons), 2021–2026

Table 20. Global Inhalation Anesthesia Sales Market Share by Region (2021–2026)

Table 21. Global Inhalation Anesthesia Sales by Region (Tons), 2027–2032

Table 22. Global Inhalation Anesthesia Sales Market Share by Region (2027–2032)

Table 23. Global Inhalation Anesthesia Revenue by Region (US$ Million), 2021–2026

Table 24. Global Inhalation Anesthesia Revenue Market Share by Region (2021–2026)

Table 25. Global Inhalation Anesthesia Revenue by Region (US$ Million), 2027–2032

Table 26. Global Inhalation Anesthesia Revenue Market Share by Region (2027–2032)

Table 27. North America Inhalation Anesthesia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Inhalation Anesthesia Sales by Country (Tons), 2021–2026

Table 29. North America Inhalation Anesthesia Sales by Country (Tons), 2027–2032

Table 30. North America Inhalation Anesthesia Revenue by Country (US$ Million), 2021–2026

Table 31. North America Inhalation Anesthesia Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Inhalation Anesthesia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Inhalation Anesthesia Sales by Country (Tons), 2021–2026

Table 34. Europe Inhalation Anesthesia Sales by Country (Tons), 2027–2032

Table 35. Europe Inhalation Anesthesia Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Inhalation Anesthesia Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Inhalation Anesthesia Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Inhalation Anesthesia Sales by Region (Tons), 2021–2026

Table 39. Asia Pacific Inhalation Anesthesia Sales by Region (Tons), 2027–2032

Table 40. Asia Pacific Inhalation Anesthesia Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Inhalation Anesthesia Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Inhalation Anesthesia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Inhalation Anesthesia Sales by Country (Tons), 2021–2026

Table 44. Latin America Inhalation Anesthesia Sales by Country (Tons), 2027–2032

Table 45. Latin America Inhalation Anesthesia Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Inhalation Anesthesia Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Inhalation Anesthesia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Inhalation Anesthesia Sales by Country (Tons), 2021–2026

Table 49. Middle East and Africa Inhalation Anesthesia Sales by Country (Tons), 2027–2032

Table 50. Middle East and Africa Inhalation Anesthesia Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Inhalation Anesthesia Revenue by Country (US$ Million), 2027–2032

Table 52. Global Inhalation Anesthesia Sales (Tons) by Type (2021–2026)

Table 53. Global Inhalation Anesthesia Sales (Tons) by Type (2027–2032)

Table 54. Global Inhalation Anesthesia Sales Market Share by Type (2021–2026)

Table 55. Global Inhalation Anesthesia Sales Market Share by Type (2027–2032)

Table 56. Global Inhalation Anesthesia Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Inhalation Anesthesia Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Inhalation Anesthesia Revenue Market Share by Type (2021–2026)

Table 59. Global Inhalation Anesthesia Revenue Market Share by Type (2027–2032)

Table 60. Global Inhalation Anesthesia Price (US$/kg) by Type (2021–2026)

Table 61. Global Inhalation Anesthesia Price (US$/kg) by Type (2027–2032)

Table 62. Global Inhalation Anesthesia Sales (Tons) by Application (2021–2026)

Table 63. Global Inhalation Anesthesia Sales (Tons) by Application (2027–2032)

Table 64. Global Inhalation Anesthesia Sales Market Share by Application (2021–2026)

Table 65. Global Inhalation Anesthesia Sales Market Share by Application (2027–2032)

Table 66. Global Inhalation Anesthesia Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Inhalation Anesthesia Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Inhalation Anesthesia Revenue Market Share by Application (2021–2026)

Table 69. Global Inhalation Anesthesia Revenue Market Share by Application (2027–2032)

Table 70. Global Inhalation Anesthesia Price (US$/kg) by Application (2021–2026)

Table 71. Global Inhalation Anesthesia Price (US$/kg) by Application (2027–2032)

Table 72. Baxter Company Information

Table 73. Baxter Description and Business Overview

Table 74. Baxter Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 75. Baxter Inhalation Anesthesia Product

Table 76. Baxter Recent Developments/Updates

Table 77. AbbVie Company Information

Table 78. AbbVie Description and Business Overview

Table 79. AbbVie Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 80. AbbVie Inhalation Anesthesia Product

Table 81. AbbVie Recent Developments/Updates

Table 82. Piramal Critical Care Company Information

Table 83. Piramal Critical Care Description and Business Overview

Table 84. Piramal Critical Care Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 85. Piramal Critical Care Inhalation Anesthesia Product

Table 86. Piramal Critical Care Recent Developments/Updates

Table 87. Fresenius Kabi Company Information

Table 88. Fresenius Kabi Description and Business Overview

Table 89. Fresenius Kabi Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 90. Fresenius Kabi Inhalation Anesthesia Product

Table 91. Fresenius Kabi Recent Developments/Updates

Table 92. Halocarbon Company Information

Table 93. Halocarbon Description and Business Overview

Table 94. Halocarbon Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 95. Halocarbon Inhalation Anesthesia Product

Table 96. Halocarbon Recent Developments/Updates

Table 97. Aspen Company Information

Table 98. Aspen Description and Business Overview

Table 99. Aspen Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 100. Aspen Inhalation Anesthesia Product

Table 101. Aspen Recent Developments/Updates

Table 102. Pfizer Company Information

Table 103. Pfizer Description and Business Overview

Table 104. Pfizer Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 105. Pfizer Inhalation Anesthesia Product

Table 106. Pfizer Recent Developments/Updates

Table 107. Maruishi Pharmaceutical Company Information

Table 108. Maruishi Pharmaceutical Description and Business Overview

Table 109. Maruishi Pharmaceutical Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 110. Maruishi Pharmaceutical Inhalation Anesthesia Product

Table 111. Maruishi Pharmaceutical Recent Developments/Updates

Table 112. Jiangsu Hengrui Medicine Company Information

Table 113. Jiangsu Hengrui Medicine Description and Business Overview

Table 114. Jiangsu Hengrui Medicine Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 115. Jiangsu Hengrui Medicine Inhalation Anesthesia Product

Table 116. Jiangsu Hengrui Medicine Recent Developments/Updates

Table 117. Lunan Pharmaceutical Company Information

Table 118. Lunan Pharmaceutical Description and Business Overview

Table 119. Lunan Pharmaceutical Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 120. Lunan Pharmaceutical Inhalation Anesthesia Product

Table 121. Lunan Pharmaceutical Recent Developments/Updates

Table 122. Hikma Pharmaceuticals Company Information

Table 123. Hikma Pharmaceuticals Description and Business Overview

Table 124. Hikma Pharmaceuticals Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 125. Hikma Pharmaceuticals Inhalation Anesthesia Product

Table 126. Hikma Pharmaceuticals Recent Developments/Updates

Table 127. HeBei YiPin Pharmaceutical Company Information

Table 128. HeBei YiPin Pharmaceutical Description and Business Overview

Table 129. HeBei YiPin Pharmaceutical Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 130. HeBei YiPin Pharmaceutical Inhalation Anesthesia Product

Table 131. HeBei YiPin Pharmaceutical Recent Developments/Updates

Table 132. Dechra Pharmaceuticals Company Information

Table 133. Dechra Pharmaceuticals Description and Business Overview

Table 134. Dechra Pharmaceuticals Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 135. Dechra Pharmaceuticals Inhalation Anesthesia Product

Table 136. Dechra Pharmaceuticals Recent Developments/Updates

Table 137. Life Sciences Company Information

Table 138. Life Sciences Description and Business Overview

Table 139. Life Sciences Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 140. Life Sciences Inhalation Anesthesia Product

Table 141. Life Sciences Recent Developments/Updates

Table 142. Zhejiang AngLiKang Pharmaceutical Company Information

Table 143. Zhejiang AngLiKang Pharmaceutical Description and Business Overview

Table 144. Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 145. Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Product

Table 146. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates

Table 147. Linde Healthcare Company Information

Table 148. Linde Healthcare Description and Business Overview

Table 149. Linde Healthcare Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 150. Linde Healthcare Inhalation Anesthesia Product

Table 151. Linde Healthcare Recent Developments/Updates

Table 152. Air Liquide Company Information

Table 153. Air Liquide Description and Business Overview

Table 154. Air Liquide Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 155. Air Liquide Inhalation Anesthesia Product

Table 156. Air Liquide Recent Developments/Updates

Table 157. Messer Company Information

Table 158. Messer Description and Business Overview

Table 159. Messer Inhalation Anesthesia Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 160. Messer Inhalation Anesthesia Product

Table 161. Messer Recent Developments/Updates

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Inhalation Anesthesia Distributors List

Table 165. Inhalation Anesthesia Customers List

Table 166. Inhalation Anesthesia Market Trends

Table 167. Inhalation Anesthesia Market Drivers

Table 168. Inhalation Anesthesia Market Challenges

Table 169. Inhalation Anesthesia Market Restraints

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

Table 173. Authors List of This Report

List of Figures

Figure 1. Product Picture of Inhalation Anesthesia

Figure 2. Global Inhalation Anesthesia Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Inhalation Anesthesia Market Share by Type: 2025 & 2032

Figure 4. Heptafluoroane Product Picture

Figure 5. Desflurane Product Picture

Figure 6. Isoflurane Product Picture

Figure 7. Others Product Picture

Figure 8. Global Inhalation Anesthesia Market Value by MAC (US$ Million), 2021–2032

Figure 9. Global Inhalation Anesthesia Market Share by MAC: 2025 vs 2032

Figure 10. Below 3% Product Picture

Figure 11. Above 3% Product Picture

Figure 12. Global Inhalation Anesthesia Market Value by Chemical Structure (US$ Million), 2021–2032

Figure 13. Global Inhalation Anesthesia Market Share by Chemical Structure: 2025 vs 2032

Figure 14. Volatile Gases Product Picture

Figure 15. Liquids Product Picture

Figure 16. Global Inhalation Anesthesia Market Value by Application (US$ Million), 2021–2032

Figure 17. Global Inhalation Anesthesia Market Share by Application: 2025 & 2032

Figure 18. Human Use

Figure 19. Animal Use

Figure 20. Global Inhalation Anesthesia Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Inhalation Anesthesia Market Size (US$ Million), 2021–2032

Figure 22. Global Inhalation Anesthesia Sales (Tons), 2021–2032

Figure 23. Global Inhalation Anesthesia Average Price (US$/kg), 2021–2032

Figure 24. Inhalation Anesthesia Report Years Considered

Figure 25. Inhalation Anesthesia Sales Share by Manufacturers in 2025

Figure 26. Global Inhalation Anesthesia Revenue Share by Manufacturers in 2025

Figure 27. Top 5 and Top 10 Global Inhalation Anesthesia Players: Market Share by Revenue in Inhalation Anesthesia in 2025

Figure 28. Inhalation Anesthesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 29. Global Inhalation Anesthesia Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 30. North America Inhalation Anesthesia Sales Market Share by Country (2021–2032)

Figure 31. North America Inhalation Anesthesia Revenue Market Share by Country (2021–2032)

Figure 32. U.S. Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Canada Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Europe Inhalation Anesthesia Sales Market Share by Country (2021–2032)

Figure 35. Europe Inhalation Anesthesia Revenue Market Share by Country (2021–2032)

Figure 36. Germany Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. France Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. U.K. Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Italy Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Russia Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Asia Pacific Inhalation Anesthesia Sales Market Share by Region (2021–2032)

Figure 42. Asia Pacific Inhalation Anesthesia Revenue Market Share by Region (2021–2032)

Figure 43. China Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Japan Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. South Korea Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. India Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Australia Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Taiwan Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Indonesia Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Thailand Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Malaysia Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Philippines Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Latin America Inhalation Anesthesia Sales Market Share by Country (2021–2032)

Figure 54. Latin America Inhalation Anesthesia Revenue Market Share by Country (2021–2032)

Figure 55. Mexico Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Brazil Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Argentina Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Middle East and Africa Inhalation Anesthesia Sales Market Share by Country (2021–2032)

Figure 59. Middle East and Africa Inhalation Anesthesia Revenue Market Share by Country (2021–2032)

Figure 60. Turkey Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Saudi Arabia Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. U.A.E Inhalation Anesthesia Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Global Sales Market Share of Inhalation Anesthesia by Type (2021–2032)

Figure 64. Global Revenue Market Share of Inhalation Anesthesia by Type (2021–2032)

Figure 65. Global Inhalation Anesthesia Price (US$/kg) by Type (2021–2032)

Figure 66. Global Sales Market Share of Inhalation Anesthesia by Application (2021–2032)

Figure 67. Global Revenue Market Share of Inhalation Anesthesia by Application (2021–2032)

Figure 68. Global Inhalation Anesthesia Price (US$/kg) by Application (2021–2032)

Figure 69. Inhalation Anesthesia Value Chain

Figure 70. Channels of Distribution (Direct Vs Distribution)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions